 |
 |
 |
|
TLR7 Agonist GS-9620 Activates HIV-1 in PBMCs from HIV-Infected Patients on cART
|
|
|
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
D Sloan1, A Irrinki1, A Tsai1, J Kaur1, J Lalezari2, J Murry1, T Cihlar1
1Gilead Sciences Inc., Foster City, CA, 2Quest Clinical Research, San Francisco, CA






|
|
|
 |
 |
|
|